Author

E. Ferri

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Approach:deep learning· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:multiome· 1

Frequent Co-Authors

A. Ashkenazi· 1 shared A. Ghez Farrell· 1 shared A. J. Greaney· 1 shared A. Le Thomas· 1 shared A. N. Loes· 1 shared B. Dadonaite· 1 shared D. Corti· 1 shared D. Veesler· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Ashkenazi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Shifting mutational constraints in the SARS-CoV-2 receptor-binding domain during viral evolution

T. N. Starr, A. J. Greaney, W. W. Hannon, A. N. Loes, K. Hauser, J. R. Dillen, E. Ferri, A. Ghez Farrell, B. Dadonaite, M. McCallum, K. A. Matreyek, D. Corti, D. Veesler, G. Snell, J. D. Bloom

The paper analyzes epistatic shifts in SARS-CoV-2 RBD mutations across variants to understand how they influence ACE2 binding and future evolution.

bioRxiv · Feb 24, 2022Microbiology

Noncanonical mRNA decay by the endoplasmic-reticulum stress sensor IRE1α promotes cancer-cell survival

A. Le Thomas, E. Ferri, S. Marsters, J. M. Harnoss, Z. Modrusan, W. Li, J. Rudolph, W. Wang, T. D. Wu, P. Walter, A. Ashkenazi

The paper identifies a noncanonical mRNA decay process, RIDDLE, mediated by IRE1α oligomers in cancer cells, which promotes survival by degrading mRNAs without XBP1-like endomotifs.

bioRxiv · Mar 16, 2021 · PreprintCancer Biology